F. Hoffmann-La Roche had 12 patents in internet of things during Q4 2023. The patents filed by F. Hoffmann-La Roche Ltd in Q4 2023 include methods for determining system resistance of power supplies in medical devices, processing data from analytical instruments, detecting medical device efficiency using PPG sensors, and alerting users about blood glucose levels. These inventions aim to improve the functionality and accuracy of medical devices and ensure timely notifications for critical health conditions. GlobalData’s report on F. Hoffmann-La Roche gives a 360-degreee view of the company including its patenting strategy. Buy the report here.
F. Hoffmann-La Roche grant share with internet of things as a theme is 25% in Q4 2023. Grant share is based on the ratio of number of grants to total number of patents.
Recent Patents
Application: Method for determining the system resistance of a device (Patent ID: US20230393181A1)
The patent filed by F. Hoffmann-La Roche Ltd. describes a method for determining the system resistance of a power supply in a handheld medical device. The method involves generating an excitation voltage signal with a fast transition DC flank, applying it to a reference resistor in series with the power supply, measuring the response signal, and determining the system resistance based on the ohmic signal portion. The method aims to accurately assess the power supply's performance and reliability.
Additionally, the patent includes claims related to the type of excitation voltage signal, the connection of the reference resistor, comparison of signal shapes, determination of system resistance, and implementation of failsafe measures. The device described in the patent comprises elements such as a power supply, reference resistor, signal generator, measurement unit, and evaluation device to carry out the method effectively. The device is intended for use in handheld analytical devices, insulin pumps, and portable sensors for monitoring body functions, emphasizing its application in the medical field for critical power supply monitoring.
To know more about GlobalData’s detailed insights on F. Hoffmann-La Roche, buy the report here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.